BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 278 filers reported holding BLUEPRINT MEDICINES CORP in Q2 2021. The put-call ratio across all filers is 1.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $30,233,796 | +64.2% | 602,027 | +106.6% | 0.35% | +62.4% |
| Q2 2023 | $18,414,078 | +288.4% | 291,362 | +176.5% | 0.22% | +240.6% |
| Q1 2023 | $4,740,911 | -55.0% | 105,377 | -56.2% | 0.06% | -54.6% |
| Q4 2022 | $10,544,804 | +71.4% | 240,694 | +157.7% | 0.14% | +64.0% |
| Q3 2022 | $6,153,000 | +4.9% | 93,387 | -19.6% | 0.09% | -4.4% |
| Q2 2022 | $5,864,000 | +269.0% | 116,087 | +366.7% | 0.09% | +246.2% |
| Q1 2022 | $1,589,000 | -76.1% | 24,873 | -59.9% | 0.03% | -72.6% |
| Q4 2021 | $6,647,000 | -62.4% | 62,055 | -63.9% | 0.10% | -67.1% |
| Q3 2021 | $17,687,000 | +252.4% | 172,035 | +201.5% | 0.29% | +207.4% |
| Q2 2021 | $5,019,000 | -41.9% | 57,056 | -35.8% | 0.09% | -51.0% |
| Q1 2021 | $8,644,000 | – | 88,906 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 645,539 | $69,144,000 | 7.84% |
| DAFNA Capital Management LLC | 206,911 | $22,162,000 | 5.57% |
| Eagle Health Investments LP | 192,639 | $20,634,000 | 5.03% |
| Casdin Capital, LLC | 1,550,000 | $166,021,000 | 4.68% |
| CADIAN CAPITAL MANAGEMENT, LP | 450,657 | $48,270,000 | 2.65% |
| Avidity Partners Management LP | 995,000 | $106,574,000 | 2.26% |
| Integral Health Asset Management, LLC | 75,000 | $8,033,000 | 2.22% |
| Rock Springs Capital Management LP | 859,755 | $92,088,000 | 2.13% |
| Boxer Capital, LLC | 507,374 | $54,345,000 | 2.11% |
| EFG Asset Management (North America) Corp. | 112,715 | $12,082,000 | 1.58% |